High-dose Flu Vaccine Cuts Hospitalizations for Nursing Home Residents High-dose Flu Vaccine Cuts Hospitalizations for Nursing Home Residents

Compared with standard-dose influenza vaccination, high-dose influenza vaccination reduces the number of U.S. nursing home residents who require respiratory-related hospital admissions, according to results from a cluster-randomized trial.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news

Related Links:

Conditions:   Avian Influenza;   Influenza Immunisation Interventions:   Biological: A/H7N9;   Drug: AS03;   Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013;   Other: Phosphate Buffered Saline (PBS) diluent Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
(NIH/National Institute of Allergy and Infectious Diseases) Virus-like particles (VLPs) are protein-based structures that mimic viruses and bind to antibodies. Because VLPs aren't infectious, they show promise as vaccine platforms for many viral diseases, including influenza. Since details about influenza VLPs are scant, a team of researchers developed a 3D model based on the 1918 H1 pandemic influenza virus. The research, conducted by NIAID scientists, could benefit VLP vaccine projects, targeting a range of viruses from HIV to Ebola and SARS coronavirus.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
Condition:   Influenza Interventions:   Biological: H7N3 pLAIV;   Biological: H7N9 pIIV Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) have similar efficacy in children, according to results from a Canadian Immunization Research Network (CIRN) study.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
The National Institute of Allergy and Infectious Diseases (NIAID) recently launched aphase 2 clinical trial of an experimental universal influenza vaccine.
Source: JAMA - Category: General Medicine Source Type: research
Conditions:   Influenza;   Influenza Immunisation Interventions:   Biological: Influenza Virus Monovalent A/H3N2/Bris 10 M2SR Live Vaccine;   Biological: Influenza Virus Quadrivalent Inactivated Vaccine;   Other: Placebo Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Hospitals | Infectious Diseases | Influenza | Influenza Vaccine | Nurses | Nursing | Respiratory Medicine | Vaccines